The expression of programmed death-ligand 1 (PD-L1)/PD-1 could enhance tumor development via the inhibition of T-cell functions, indicating an immunosuppressive role of PD-L1/PD-1 [8,9,10]. Here, PDCD1 is linked to neoplasm.